Literature DB >> 18190618

Improving efficiency of inferences in randomized clinical trials using auxiliary covariates.

Min Zhang1, Anastasios A Tsiatis1, Marie Davidian1.   

Abstract

The primary goal of a randomized clinical trial is to make comparisons among two or more treatments. For example, in a two-arm trial with continuous response, the focus may be on the difference in treatment means; with more than two treatments, the comparison may be based on pairwise differences. With binary outcomes, pairwise odds ratios or log odds ratios may be used. In general, comparisons may be based on meaningful parameters in a relevant statistical model. Standard analyses for estimation and testing in this context typically are based on the data collected on response and treatment assignment only. In many trials, auxiliary baseline covariate information may also be available, and it is of interest to exploit these data to improve the efficiency of inferences. Taking a semiparametric theory perspective, we propose a broadly applicable approach to adjustment for auxiliary covariates to achieve more efficient estimators and tests for treatment parameters in the analysis of randomized clinical trials. Simulations and applications demonstrate the performance of the methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18190618      PMCID: PMC2574960          DOI: 10.1111/j.1541-0420.2007.00976.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   1.701


  11 in total

1.  Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.

Authors:  C M Tangen; G G Koch
Journal:  J Biopharm Stat       Date:  1999-05       Impact factor: 1.051

2.  A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.

Authors:  Emmanuel Lesaffre; Stephen Senn
Journal:  Stat Med       Date:  2003-12-15       Impact factor: 2.373

3.  Adjustment for baseline covariates: an introductory note.

Authors:  Jean-Marie Grouin; Simon Day; John Lewis
Journal:  Stat Med       Date:  2004-03-15       Impact factor: 2.373

Review 4.  Should we adjust for covariates in nonlinear regression analyses of randomized trials?

Authors:  W W Hauck; S Anderson; S M Marcus
Journal:  Control Clin Trials       Date:  1998-06

Review 5.  Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them.

Authors:  G G Koch; C M Tangen; J W Jung; I A Amara
Journal:  Stat Med       Date:  1998 Aug 15-30       Impact factor: 2.373

6.  Covariate imbalance and random allocation in clinical trials.

Authors:  S J Senn
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

7.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

Authors:  S M Hammer; D A Katzenstein; M D Hughes; H Gundacker; R T Schooley; R H Haubrich; W K Henry; M M Lederman; J P Phair; M Niu; M S Hirsch; T C Merigan
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

8.  Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes.

Authors: 
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245

9.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.

Authors:  Stuart J Pocock; Susan E Assmann; Laura E Enos; Linda E Kasten
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

10.  Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach.

Authors:  Anastasios A Tsiatis; Marie Davidian; Min Zhang; Xiaomin Lu
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

View more
  57 in total

1.  On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial.

Authors:  Lu Tian; Tianxi Cai; Lihui Zhao; Lee-Jen Wei
Journal:  Biostatistics       Date:  2012-01-30       Impact factor: 5.899

2.  Simple, efficient estimators of treatment effects in randomized trials using generalized linear models to leverage baseline variables.

Authors:  Michael Rosenblum; Mark J van der Laan
Journal:  Int J Biostat       Date:  2010-04-01       Impact factor: 0.968

3.  Adaptive pre-specification in randomized trials with and without pair-matching.

Authors:  Laura B Balzer; Mark J van der Laan; Maya L Petersen
Journal:  Stat Med       Date:  2016-07-19       Impact factor: 2.373

4.  Evaluating surrogate marker information using censored data.

Authors:  Layla Parast; Tianxi Cai; Lu Tian
Journal:  Stat Med       Date:  2017-01-15       Impact factor: 2.373

5.  Leveraging prognostic baseline variables to gain precision in randomized trials.

Authors:  Elizabeth Colantuoni; Michael Rosenblum
Journal:  Stat Med       Date:  2015-04-14       Impact factor: 2.373

6.  Robust extraction of covariate information to improve estimation efficiency in randomized trials.

Authors:  Kelly L Moore; Romain Neugebauer; Thamban Valappil; Mark J Laan
Journal:  Stat Med       Date:  2011-07-12       Impact factor: 2.373

7.  Analysis of randomized comparative clinical trial data for personalized treatment selections.

Authors:  Tianxi Cai; Lu Tian; Peggy H Wong; L J Wei
Journal:  Biostatistics       Date:  2010-09-28       Impact factor: 5.899

8.  Connections between survey calibration estimators and semiparametric models for incomplete data.

Authors:  Thomas Lumley; Pamela A Shaw; James Y Dai
Journal:  Int Stat Rev       Date:  2011-08       Impact factor: 2.217

9.  FLEXIBLE COVARIATE-ADJUSTED EXACT TESTS OF RANDOMIZED TREATMENT EFFECTS WITH APPLICATION TO A TRIAL OF HIV EDUCATION.

Authors:  Alisa J Stephens; Eric J Tchetgen Tchetgen; Victor De Gruttola
Journal:  Ann Appl Stat       Date:  2013-12-23       Impact factor: 2.083

10.  A note on compatibility for inference with missing data in the presence of auxiliary covariates.

Authors:  Michael J Daniels; Xuan Luo
Journal:  Stat Med       Date:  2018-11-18       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.